Package 59762-5030-1

{"route": ["ORAL"], "spl_id": "825a44a4-7ec9-4c4a-b04f-7e470831a511", "openfda": {"nui": ["N0000175487", "M0002083", "N0000182140", "N0000182141", "N0000185504"], "upc": ["0359762503015", "0359762501516", "0359762502919"], "unii": ["8VZV102JFY"], "rxcui": ["197698", "197699", "197700", "197701", "310352", "310353"], "spl_set_id": ["737e0fac-a2d2-4053-a0d7-edbfb6248f69"], "pharm_class_cs": ["Azoles [CS]"], "pharm_class_epc": ["Azole Antifungal [EPC]"], "pharm_class_moa": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]"], "manufacturer_name": ["Mylan Pharmaceuticals Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE in 1 CARTON (59762-5030-1)  / 35 mL in 1 BOTTLE", "package_ndc": "59762-5030-1", "marketing_start_date": "19931223"}], "brand_name": "Fluconazole", "product_id": "59762-5030_825a44a4-7ec9-4c4a-b04f-7e470831a511", "dosage_form": "POWDER, FOR SUSPENSION", "pharm_class": ["Azole Antifungal [EPC]", "Azoles [CS]", "Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 2C9 Inhibitors [MoA]", "Cytochrome P450 3A4 Inhibitors [MoA]"], "product_ndc": "59762-5030", "generic_name": "fluconazole", "labeler_name": "Mylan Pharmaceuticals Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fluconazole", "active_ingredients": [{"name": "FLUCONAZOLE", "strength": "40 mg/mL"}], "application_number": "NDA020090", "marketing_category": "NDA AUTHORIZED GENERIC", "marketing_start_date": "19931223", "listing_expiration_date": "20261231"}